References
- Folkman J. Anti-angiogenesis: New concept for therapy of solid tumours. Ann Surg. 1972; 175: 409–16
- Bibby M C, Phillips R M, Double J A. Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 34512). Cancer Chemother Pharmacol 1989; 24: 87–94
- Stratford I J, Adams G E, Godden J, Nolan J, Howells N, Timpson N. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. Br J Cancer 1988; 58: 122–7
- Bibby M C, Sleigh N R, Loadman P M, Double J A. Potentiation of EO9 antitumour activity by hydralazine. Eur J Cancer 1993; 29: 1033–5
- Bibby M C, Loadman P M, Al-Ghabban A F, Double J A. Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice. Br J Cancer 1992; 65: 347–50
- Quinn P KM, Bibby M C, Cox J A, Crawford S M. The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours. Br J Cancer 1992; 66: 323–30
- Double J A, Ball C R, Cowen P N. Transplantation of adeno-carcinomas of the colon in mice. J Natl Cancer Inst 1975; 54: 271–5
- Double J A, Cifuentes de Castro L. Chemotherapy of transplantable adenocarcinomas of the colon in mice. II. Development and characterization of an ascitic line. Cancer Treat Rep 1978; 62: 85–90
- Smith K A, Hill S A, Begg A C, Denekamp J. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. Br J Cancer 1988; 57: 247–53
- Quinn P KM, Naylor J A, Bibby M C. A comparison of the influence of 2 agents on the vasculature of MAC tumours. Br J Cancer 1992; 65(Suppl XVI)57